Apellis Pharmaceuticals (APLS) Q1 2026 Earnings

24FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.74
0.06
0.87
1.67

Details

Expected EPS
-0.374009
Actual EPS
-0.47
Surprise EPS
-0.1
Surprise Percent
+25.67%

Description

Apellis Pharmaceuticals (APLS) has reported earnings of -0.47 per share for Q1 2026.

0 Comments

Share your thoughts